SeQuent Scientific Ltd
NSE:SEQUENT
SeQuent Scientific Ltd
Revenue
SeQuent Scientific Ltd
Revenue Peer Comparison
Competitive Revenue Analysis
Latest Figures & CAGR of Competitors
Company | Revenue | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
SeQuent Scientific Ltd
NSE:SEQUENT
|
Revenue
₹13.8B
|
CAGR 3-Years
1%
|
CAGR 5-Years
7%
|
CAGR 10-Years
N/A
|
|
Dr Reddy's Laboratories Ltd
NSE:DRREDDY
|
Revenue
₹272.1B
|
CAGR 3-Years
13%
|
CAGR 5-Years
13%
|
CAGR 10-Years
N/A
|
|
Cipla Ltd
NSE:CIPLA
|
Revenue
₹253.5B
|
CAGR 3-Years
10%
|
CAGR 5-Years
10%
|
CAGR 10-Years
10%
|
|
Sun Pharmaceutical Industries Ltd
NSE:SUNPHARMA
|
Revenue
₹474.4B
|
CAGR 3-Years
13%
|
CAGR 5-Years
10%
|
CAGR 10-Years
12%
|
|
Zydus Lifesciences Ltd
NSE:ZYDUSLIFE
|
Revenue
₹186.8B
|
CAGR 3-Years
9%
|
CAGR 5-Years
8%
|
CAGR 10-Years
11%
|
|
M
|
Mankind Pharma Ltd
NSE:MANKIND
|
Revenue
₹87.5B
|
CAGR 3-Years
14%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
See Also
What is SeQuent Scientific Ltd's Revenue?
Revenue
13.8B
INR
Based on the financial report for Dec 31, 2023, SeQuent Scientific Ltd's Revenue amounts to 13.8B INR.
What is SeQuent Scientific Ltd's Revenue growth rate?
Revenue CAGR 5Y
7%
Over the last year, the Revenue growth was -4%. The average annual Revenue growth rates for SeQuent Scientific Ltd have been 1% over the past three years , 7% over the past five years .